Arturo Casadevall

Arturo Casadevall, M.D., Ph.D., is a Bloomberg Distinguished Professor and Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He obtained his B.A. in Chemistry at Queens College of the City University of New York. Previously, he served as Director of the Division of Infectious Diseases at Montefiore Medical Center, the University Hospital and Academic Medical Center for Einstein, from 2000‐2006 and as Chair of the Department of Microbiology and Immunology from 2006‐2014. Dr. Casadevall received both his M.D. and Ph.D. (biochemistry) degrees from New York University. Subsequently, he completed his internship and residency in internal medicine at Bellevue Hospital in New York. He then completed subspecialty training in infectious diseases at Montefiore and Einstein. The author of over 700 scientific papers, numerous books and book chapters, Dr. Casadevall’s major research interests are in fungal pathogenesis and the mechanisms of antibody action. In the area of biodefense, he has an active research program to understand the mechanisms of antibody‐mediated neutralization of Bacillu anthracis toxins. In recent years, Dr. Casadevall has become interested in problems with the scientific enterprise and with his collaborators shown that misconduct accounts for the majority of retracted publications. He has suggested a variety of reforms to the way science is done. Dr. Casadevall is the editor‐in‐chief of mBio, the first open access general journal of the American Society of Microbiology, and is on the editorial board of several journals including the Journal of Infectious Diseases and the Cell Surface. He has also served on numerous NIH committees including those that drafted the NIAID Strategic Plan and the Blue Ribbon Panel on Biodefense Research. He served on the National Academy of Sciences panel that reviewed the science on the FBI investigation of the anthrax terror attacks of 2001 and has served on the NAS Committee of Federal Regulations and Reporting requirements. He has also served as a member of the National Science Advisory Board for Biosecurity from 2005‐2014. In 2008, he was recognized by the American Society of Microbiology with the William Hinton Award for mentoring scientists from underrepresented groups. In 2015, Dr. Casadevall was appointed a Commissioner to the National Commission on Forensic Science, the United States Department of Justice. He has served as President of the Medical Mycology Society of America, Chair of American Society for Microbiology Division F, Chair of the American Society for Microbiology Career Development Committee, Co‐Chair of the National Institute of Allergy and Infectious Diseases Board of Scientific Counselors, and currently serves on the Scientific Council/Advisory Board for the Pasteur Institut and VIB Research Institute in Belgium. He is a member of the American Society for Clinical Investigation, American College of Physicians, Association of American Physicians, was elected Fellow of the American Association for the Advancement of Science and the American Academy of Microbiology. In 2014, he became an elected member of the National Academy of Medicine and in 2017 he was elected to the American Academy of Arts and Sciences.